STANLEY FRIEDLER, MD

Plain English
This study focused on a couple struggling with infertility and repeated failed attempts at pregnancy. They used a new 3D imaging device called the Q300, which helped select healthier sperm for assisted reproduction. As a result, they successfully achieved a pregnancy and delivered a healthy baby, demonstrating the potential of this technology to improve outcomes in challenging fertility cases. Who this helps: This benefits couples facing infertility issues, especially those with severe sperm problems.

Plain English
This study looked at a method called drug-free in vitro activation (IVA) to help women with issues like poor ovarian response and premature ovarian insufficiency. The researchers found that 71% of women with poor ovarian response had more follicles develop after treatment, and fertilization rates were 72% for these patients. For women with premature ovarian insufficiency, 50% had increased follicles, with a fertilization rate of 59%, and 5 of 14 were able to cryopreserve embryos. This is important because it offers a new option for women struggling with infertility due to these conditions. Who this helps: This helps women with poor ovarian response and premature ovarian insufficiency.

Plain English
This study looked at a new device called the Q300™ that helps select better sperm for use in fertility treatments like IVF. The research found that using the Q300™ improved embryo development and pregnancy rates; for example, there were better outcomes by Day 3 of embryo growth compared to traditional methods. This matters because it offers hope for higher success rates in treating infertility, giving more couples the chance to achieve pregnancy. Who this helps: This helps patients struggling with infertility and the doctors who treat them.

Plain English
This research focused on infertility issues related to men, which affects at least 50% of couples looking for help. The study found that understanding and treating male infertility can be challenging but also shows promise with new therapies. This is important because it can help couples achieve their dream of having children. Who this helps: This benefits couples struggling with infertility, especially those with male factor issues.

Plain English
This study looked at weight changes in women undergoing IVF treatments to see if hormone therapy causes significant weight gain. Researchers tracked the weights of 519 patients through three treatment cycles and found the average weight change was only about 0.26 to 0.4 pounds, which is less than 1% of their body weight, far below the 5-7% that would be considered significant. This matters because it dispels the myth that IVF treatments lead to major weight gain, easing worries for women considering this option. Who this helps: This helps patients undergoing IVF treatments by reducing their concerns about weight gain.

Plain English
This study looked at how falling levels of estradiol, a hormone important for egg development, impact the success of in vitro fertilization (IVF). Researchers analyzed 2,417 IVF cycles and found that when estradiol levels dropped before triggering ovulation, patients ended up with fewer eggs—5 eggs on average compared to 7 in cycles without this hormone drop. This matters because having fewer eggs can lower the chances of a successful pregnancy during IVF treatments. Who this helps: Patients undergoing IVF.

Plain English
This study looked at how beta-hCG hormone levels change after embryo transfer in two types of IVF cycles: fresh (FRET) and frozen-thawed (FET). Researchers found that beta-hCG levels on day 14 were significantly higher in pregnancies from frozen embryos compared to fresh ones, with average levels of 450 IU/L vs. 183 IU/L, and on day 16, levels were 348 IU/L vs. 735 IU/L. These findings are important because they can help predict outcomes for the pregnancies, like the chance of a live birth, and guide doctors in interpreting early pregnancy tests. Who this helps: This helps doctors and patients undergoing IVF treatment.

Plain English
This study looked at a case of severe ovarian hyperstimulation syndrome (OHSS) that occurred even after patients received support using a specific hormone treatment called GnRH agonist. The findings show that using this treatment does not remove the risk of developing OHSS in patients at high risk, which goes against earlier beliefs. This is important because it highlights the need for doctors to look for additional ways to prevent OHSS in these patients. Who this helps: Patients undergoing fertility treatments.

Plain English
This study looked at how acute myeloid leukemia (AML) and its treatment affect male fertility by using mice with leukemia. Researchers found that leukemia and chemotherapy together led to significantly lower sperm counts, poor sperm movement, and more abnormal sperm shapes. Also, male fertility dropped, resulting in fewer offspring delivered. Who this helps: This research benefits men with leukemia, especially those concerned about their fertility.

Plain English
This study looked at the ratio of progesterone levels to the number of eggs retrieved during IVF cycles to see if it could predict the chances of getting pregnant and having a baby. Researchers analyzed nearly 2,700 IVF cycles and found that higher ratios of progesterone to eggs were linked to lower pregnancy rates, with just 8% of women achieving pregnancy and about 6% delivering a baby when the ratio was high. Understanding this relationship helps doctors determine whether to proceed with embryo transfers when progesterone levels are elevated. Who this helps: This information benefits doctors and patients undergoing IVF treatments.

Plain English
This study looked at how patients felt after experiencing either a visit from a medical clown or watching a funny video following in vitro fertilization procedures. Out of 200 participants, those who had the clown visit rated their experience higher, particularly noting it reduced their anxiety and was more enjoyable than the film. Since many patients found the clown visit to be a very positive addition, this suggests that such interventions can improve the emotional experience during stressful medical procedures. Who this helps: This helps patients undergoing fertility treatments.

Plain English
This study looked at how a woman's body mass index (BMI) affects the chances of having a baby through IVF treatment. Researchers examined 1,654 IVF cycles and found that, while higher BMI groups had some differences like lower endometrial thickness, the overall success rates for pregnancies and live births were similar across all groups. This is important because it shows that BMI should not be a reason to deny someone access to IVF treatment. Who this helps: This helps patients seeking IVF, especially those with higher BMIs who face potential treatment barriers.

Plain English
This study looked at how women with Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome can still have children through gestational surrogacy and in vitro fertilization (IVF). Out of 140 women studied, 125 tried IVF with surrogates, leading to the birth of 71 babies. The findings highlight that there isn’t enough reliable information on this subject, which means that better data collection is needed for more informed decisions about reproductive options for these women. Who this helps: This benefits women with MRKH syndrome and their families.

Plain English
The study focused on a procedure called tubal canalization (TC) used for women diagnosed with proximal tubal occlusion (PTO), which can cause infertility. Out of 61 women who underwent TC, 93% had their fallopian tubes opened again, and 43% of those who responded to a survey were able to conceive, resulting in a 65% live birth rate among those pregnancies. This finding is important because it shows that TC is a safe and effective option for many women facing infertility, helping them avoid more costly and invasive treatments. Who this helps: This helps women with proximal tubal occlusion seeking fertility solutions.

Plain English
This study looked at the effects of different daily doses of gonadotropins, a hormone used in fertility treatments, on the chances of having a live baby. Researchers analyzed nearly 1,400 treatment cycles and found that as the daily dose increased, the success rates decreased: only 4.7% of patients in the highest dose group had live births compared to 25.9% in the control group receiving lower doses. This matters because it suggests that using very high doses of gonadotropins in fertility treatments might be harmful rather than helpful. Who this helps: This information benefits patients undergoing assisted reproductive technology.

Plain English
This study looked at intrauterine insemination (IUI), a common treatment for couples facing difficulties getting pregnant and for women using donor sperm. Researchers found that factors like the woman’s age and the quality of the man’s sperm play important roles in how successful IUI can be, but they noted that there are still many unanswered questions, such as the best methods for preparing sperm and the optimal number of treatment cycles. This matters because clearer guidelines could improve chances for couples struggling with infertility. Who this helps: This helps couples trying to conceive and fertility specialists.

Plain English
This study looked at how hormones affect the expression of a protein called PEDF in the lining of the uterus. Researchers found that steroid hormones, specifically estrogen and progesterone, play a key role: estrogen lowers PEDF levels while progesterone raises them. Notably, PEDF levels fluctuate throughout the menstrual cycle, being lowest during the early phases and highest just before menstruation, indicating its importance in reproductive health. Who this helps: This research benefits patients dealing with reproductive health issues and can inform doctors about hormonal influences on the uterus.

Plain English
This study looked at the presence of anatomical issues in the reproductive system of women whose male partners had severe infertility issues. Researchers examined 376 tests and found that 25.5% of the women showed abnormalities, with higher rates in older women: 52% for those 35 and older, compared to 18% for those under 35. This matters because it shows that even when male infertility is the main issue, women’s reproductive health can also be affected, especially as they get older. Who this helps: This helps couples struggling with infertility, particularly older women.

Plain English
This study looked at two methods of fertilizing eggs in couples dealing with endometriosis: conventional IVF and ICSI. The researchers found that ICSI led to a higher fertilization rate (73.3% compared to 54.7% with IVF) and produced more embryos at day 2 (5.2 compared to 3.6). However, when it came to actual pregnancy outcomes, there was no significant difference between the two methods. Who this helps: This helps couples struggling with infertility due to endometriosis.

Plain English
This study looked at men with a sperm condition called cryptozoospermia and compared the success rates of two types of sperm used in a fertility treatment called intracytoplasmic sperm injection (ICSI): sperm from ejaculation and sperm extracted directly from the testicles. Out of 116 ICSI cycles analyzed, those using testicular sperm led to a significantly higher rate of pregnancies (42.5%) compared to those using ejaculated sperm (15.1%). This matters because it shows that men who struggle to conceive with ejaculated sperm may have better chances of pregnancy if they use sperm extracted from their testicles. Who this helps: This helps men with fertility issues and their partners.

Plain English
This study looked at whether applying seminal plasma inside the vagina after egg retrieval could improve the chances of pregnancy for women undergoing in vitro fertilization (IVF). Researchers found that of the women who received seminal plasma, about 36.9% became pregnant, compared to 29.1% in the control group, which is a notable improvement. This matters because even a small boost in pregnancy rates can significantly impact the success of IVF treatments and help families grow. Who this helps: Patients undergoing IVF treatment.

Plain English
This study looked at how different levels of oxygen in the environment affect the development of embryos from 258 women undergoing fertility treatments. The researchers found that embryos incubated with 5% oxygen had better outcomes, including a higher percentage of top-quality embryos (31.6% compared to 23.1% with 20% oxygen), higher rates of implantation and pregnancy, and a live birth rate of 34.2% versus 15.8%. These findings are important because they indicate that lower oxygen levels can improve the chances of successful pregnancies and healthy births. Who this helps: This helps patients undergoing fertility treatments and the doctors who care for them.

Plain English
This study looked at a protein called IL-18 in the testicular tissue of both fertile and infertile men to see how it relates to sperm production. Researchers found that in men with sperm production issues, the levels of IL-18 were much lower compared to healthy men, suggesting a connection between IL-18 levels and sperm health. This matters because understanding IL-18's role could lead to better insights into male infertility and potential treatments. Who this helps: This helps patients struggling with infertility and the doctors treating them.

Plain English
This study looked at how women with Mayer-Rokitansky-Küster-Hauser syndrome (MRKH) perform in surrogate in vitro fertilization (IVF) based on whether they have the typical or atypical form of the condition. Researchers analyzed 102 IVF cycles from 27 women and found that those with the typical form required fewer hormone treatments and produced more eggs and embryos compared to those with the atypical form. However, pregnancy success rates were similar between both groups, suggesting that while treatment may differ, the end results for surrogacy can be comparable. Who this helps: This information benefits doctors and fertility specialists working with patients who have MRKH.

Plain English
This study looked at how well women with cancer respond to fertility treatments compared to healthy women. It found that women with cancer collected fewer eggs during the treatment—about 30% fewer than healthy women, although both groups had similar rates of cycle cancellations. Understanding this difference is important because it helps set realistic expectations for women with cancer who want to preserve their fertility before undergoing treatments like chemotherapy. Who this helps: This helps women with cancer considering fertility preservation options.

Plain English
This study looked at how well a new computerized system can evaluate sperm development in men who have non-obstructive azoospermia, a condition where sperm is not present due to issues in the testes. Researchers found that in these patients, the ratio of haploid (sperm) cells was very low—only about 9.6% compared to 67.6% in healthy controls. This matters because it gives doctors a better way to assess the likelihood of finding sperm during a testicular extraction procedure, which can help in planning treatment for infertility. Who this helps: This helps patients with azoospermia and their doctors.

Plain English
This study looked at a 29-year-old woman who has both Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome and a rare genetic condition called triple X karyotype. She underwent five attempts at in vitro fertilization (IVF) using a surrogate, but none were successful because her body responded poorly, retrieving only five eggs in total. This research is important because it highlights how rare genetic conditions can impact fertility treatments, guiding future care for patients with similar conditions. Who this helps: This helps doctors and patients with MRKH syndrome or triple X karyotype understand the potential challenges in fertility treatments.

Plain English
This study looked at how medical clowning, or having a clown visit patients, affects pregnancy rates after in vitro fertilization (IVF) and embryo transfer. It found that 36.4% of women who had a clown visit became pregnant, compared to only 20.2% of those who did not have the visit. This shows that adding humor and joy could help improve pregnancy chances for couples undergoing IVF. Who this helps: This helps couples trying to conceive through IVF.

Plain English
This study looked at whether frozen sperm collected from deceased men in Israel was used by their families from 2003 to 2010. Out of 10 samples, only one was requested by a sister, while four widows chose to discard the sperm and others were not interested in keeping it. This finding shows that there may not be a strong demand for postmortem sperm, suggesting that the practice of collecting it might need to be reevaluated. Who this helps: This information is relevant for families of deceased men and medical professionals involved in reproductive health.

Plain English
This study looked at the chromosomes of embryos created from immature eggs taken during IVF treatment. Researchers found that embryos from eggs that matured in the lab had better fertilization rates (58.5% compared to 43.9%) and more cells (5.7 vs. 5.0) than those from eggs that did not mature properly. However, a shocking 80.6% of these embryos had chromosomal abnormalities, with nearly all (97.2%) from eggs that didn't mature at all being affected after 24 hours. This is important because it suggests that embryos from immature eggs are often not healthy enough to use for pregnancy, so reconsidering their use might be needed. Who this helps: This helps doctors and fertility specialists make better decisions about using embryos in IVF treatments.

Plain English
This study looked at the practice of collecting and freezing sperm from deceased men in Israel, especially when families request it. Between 2003 and June 2009, sperm was successfully retrieved from 17 men, and 16 of those samples had moving sperm, which was then frozen in 15 cases. However, none of these frozen samples has been used so far, highlighting a gap between legal guidelines and actual practice. Who this helps: This helps families of deceased men looking to have children after loss.

Plain English
This study looked at how severe ovarian hyperstimulation syndrome (OHSS) affects pregnancy outcomes in women who undergo in-vitro fertilization (IVF). It found that women with severe OHSS are at higher risk for complications during pregnancy, such as multiple pregnancies, gestational diabetes, placental abruption, and having low birthweight babies. Given these findings, pregnancies complicated by OHSS should be treated as high-risk, and doctors may need to adopt gentler IVF stimulation methods to prevent OHSS from occurring. Who this helps: This helps patients undergoing IVF, particularly those at risk of severe OHSS.

Plain English
This study looked at whether giving a specific hormone (GnRH agonist) right before egg retrieval could boost pregnancy chances in women undergoing IVF using a different hormone treatment (GnRH antagonist). The researchers found that when women received the GnRH agonist, the implantation rate was 19.9% compared to 13.9% in those who didn't get it, and the overall pregnancy rate was 44.3% versus 29.1% in completed cycles. This is important because it shows that this additional hormone treatment can significantly increase the likelihood of pregnancy for women undergoing this type of IVF. Who this helps: This helps women undergoing IVF treatment who are using GnRH antagonist protocols.

Plain English
This study looked at whether women who undergo in vitro fertilization (IVF) are at a higher risk of developing breast cancer. Among 3,375 women treated with IVF, 35 were diagnosed with breast cancer, which is more than expected based on general population statistics. The results indicate that older age (40 years and up), hormonal infertility, and undergoing more than four IVF cycles may increase the risk of breast cancer. Who this helps: This information is valuable for patients considering IVF and their doctors.

Plain English
This study looked at the shape of sperm cells and their chromosomal health by analyzing over 12,000 sperm from men with abnormal sperm shapes (teratozoospermia and globozoospermia) and from healthy donors. It found that 5.3% of sperm from men with teratozoospermia and 6.7% from the globozoospermic patient had chromosomal abnormalities, compared to just 1.6% in healthy donors. This matters because it shows that abnormal sperm shape is linked to higher rates of chromosome issues, which could affect fertility and the health of potential offspring. Who this helps: This research helps patients struggling with infertility due to abnormal sperm shapes.

Plain English
This study looked at how causing a small injury to the lining of the uterus (endometrium) before starting fertility treatments affects the chances of pregnancy in women who have struggled to become pregnant after many attempts. The researchers found that women who had this local injury experienced better results, leading to higher rates of successful implantation and pregnancies. Specifically, patients who previously had four or more failed attempts and had tried transferring 12 or more embryos were more likely to have successful pregnancies after the procedure. Who this helps: This benefits patients undergoing fertility treatments, particularly those who have faced multiple failed attempts.

Plain English
This study looked at 102 women with insulin-resistant polycystic ovary syndrome (PCOS) and tested the effects of a vitamin B preparation, metformin, or both on a substance called homocysteine in their blood, which can affect health. The results showed that both treatments lowered homocysteine levels, but vitamin B was more effective; women taking vitamin B had higher pregnancy rates as well. This is important because it suggests that vitamin B could improve fertility in these women. Who this helps: This helps women with insulin-resistant PCOS who are trying to conceive.

Plain English
This study looked at whether using a special embryo transfer fluid containing hyaluronan (HA) could help women under 43 years old who had experienced multiple failures in IVF procedures. Out of 101 participants, those who used the HA fluid had a much higher success rate: 35.2% became clinically pregnant compared to 10% in the regular fluid group. This matters because it shows that HA-enriched fluid can significantly improve the chances of pregnancy for women who have struggled with IVF. Who this helps: This helps women undergoing IVF treatment, especially those with repeated failures.

Plain English
This study looked at how changing the timing between a hormone injection and the retrieval of eggs affects the number of mature eggs in women undergoing fertility treatments. Researchers found that women who had the hormone injection 3-4 hours earlier produced 72% mature eggs, compared to only 50% in the previous cycle. This is important because more mature eggs lead to better quality embryos and higher chances of pregnancy. Who this helps: Patients trying to conceive through fertility treatments.

Plain English
This study looked at how a substance called prostaglandin E2 (PGE2) affects certain growth factors in cells involved in ovulation, specifically human granulosa cells. Researchers found that when these cells were exposed to PGE2, the production of two key growth factors, amphiregulin (Ar) and epiregulin (Ep), increased significantly, mimicking the effects of another hormone called LH. Specifically, PGE2 boosted Ar and Ep levels in a dose-dependent way, and using a specific inhibitor to block PGE2 reduced the synthesis of these growth factors even when LH was present, which could explain why that inhibitor interferes with the ovulation process. Who this helps: This research benefits patients undergoing fertility treatments and their doctors by improving understanding of the mechanisms involved in ovulation.

Plain English
This study explored a special procedure to collect eggs from women with Rokitansky syndrome, a condition where the uterus is underdeveloped or absent. Researchers successfully retrieved eggs using ultrasound guidance in four treatment cycles, leading to successful fertilization and embryo transfer. This approach is important because it shows that women with this rare condition can still participate in in vitro fertilization (IVF) and have a chance to become parents. Who this helps: This helps women with Rokitansky syndrome who wish to conceive through surrogacy.